More women are now living for many years after breast cancer treatments. But when treatment ends, new problems can begin. For most women the end of treatment is accompanied by lingering side effects, including problems resulting from treatment that can come up years later.
The research was published online on Aug. Overall, the study includes information from more thanpostmenopausal women who were ages 50 to 79 when they joined from to The WHI wants to find any links between health, diet, and lifestyle factors and health problems such as cancer.
My doctor prescribed a low-dose vaginal estrogen cream, applied twice a week, for atrophic vaginitis. I've heard this dose is so low that it carries no health risk. Do you agree?
A sweeping new analysis adds to the evidence that many women who take hormone therapy during menopause are more likely to develop breast cancer—and remain at higher risk of cancer for more than a decade after they stop taking the drugs. The longer women took the medicine, the more likely they were to develop breast cancer. Experts say the findings could shape how women and their health care providers decide how to manage symptoms of menopause.
Prescription creams, rings or tablets that release estrogen locally in the vagina are available to treat the problem. But whether these products are safe for women who have had an estrogen-fueled tumor remains an open question. The American Cancer Society estimates that more than 3 million breast cancer survivors are in the U.
A sweeping new analysis adds to the evidence that many women who take hormone therapy during menopause are more likely to develop breast cancer — and remain at higher risk of cancer for more than a decade after they stop taking the drugs. The study, published Thursday in the Lancetlooked at data from dozens of studies, including long-term data on more thanwomen who developed breast cancer after menopause. The longer women took the medicine, the more likely they were to develop breast cancer.
Moreover, women taking 0. Stefanick, Ph. Action Points Explain to patients who ask that estrogen therapy has been linked to increased risk of stroke, DVT, and cardiovascular disease. Explain to patients who ask that current recommendations suggest that hormone therapy should be initiated at low doses for a limited period two to three years.
Member contributors included Ruth Farrell, MD. This document reflects emerging clinical and scientific advances as of the date issued and is subject to change. The information should not be construed as dictating an exclusive course of treatment or procedure to be followed.
For decades, women have used hormone therapy to ease symptoms of menopause, such as hot flashes and sweating. But well-conducted studies have led many doctors to conclude that the risks of MHT often outweigh the benefits. It does not discuss other possible risks of MHT such as heart disease or stroke.